SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
18-Nov-24 7:35 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 18-Nov-24 | Purchase | 58,295 | $18.12 | $1,056,180.00 | < 1% 9.26M to 9.32M | |
18-Nov-24 7:35 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-24 | Purchase | 277,246 | $17.09 | $4,739,190.00 | 3% 8.98M to 9.26M | |
18-Nov-24 7:35 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 14-Nov-24 | Purchase | 96,399 | $16.37 | $1,578,160.00 | 1% 8.88M to 8.98M | |
04-Oct-24 5:58 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 04-Oct-24 | Purchase | 80,301 | $22.58 | $1,813,010.00 | < 1% 8.8M to 8.88M | |
04-Oct-24 5:58 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 03-Oct-24 | Purchase | 119,906 | $19.89 | $2,384,710.00 | 1% 8.68M to 8.8M | |
04-Oct-24 5:58 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 02-Oct-24 | Acquisition (other) | 1,801,310 | -- | -- | 21% 8.68M to 10.48M | |
04-Oct-24 5:58 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 02-Oct-24 | Acquisition (other) | 317,879 | -- | -- | 3% 10.48M to 10.8M | |
04-Oct-24 5:58 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 02-Oct-24 | Disposition (other) | 2,119,190 | -- | -- | (20%) 10.8M to 8.68M | |
04-Oct-24 5:58 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 02-Oct-24 | Purchase | 5,514 | $17.38 | $95,821.70 | < 1% 10.8M to 10.8M | |
26-Sep-24 6:15 PM View: | Tectonic Therapeutic, Inc. (TECX) | 26-Sep-24 | Purchase | 50,000 | $28.82 | $1,440,830.00 | 1% 4.24M to 4.29M | |
27-Sep-24 4:13 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 25-Sep-24 | Option Exercise | 1,636,830 | -- | -- | 19% 8.68M to 10.32M | |
27-Sep-24 4:13 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 25-Sep-24 | Option Exercise | 722,668 | -- | -- | 7% 10.32M to 11.04M | |
27-Sep-24 4:13 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 25-Sep-24 | Option Exercise | 1,636,830 | -- | -- | (15%) 11.04M to 9.4M | |
27-Sep-24 4:13 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 25-Sep-24 | Option Exercise | 722,668 | -- | -- | (8%) 9.4M to 8.68M | |
26-Sep-24 6:15 PM View: | Tectonic Therapeutic, Inc. (TECX) | 24-Sep-24 | Acquisition (other) | 1,054,760 | -- | -- | 25% 4.24M to 5.3M | |
26-Sep-24 6:15 PM View: | Tectonic Therapeutic, Inc. (TECX) | 24-Sep-24 | Acquisition (other) | 186,134 | -- | -- | 4% 5.3M to 5.48M | |
26-Sep-24 6:15 PM View: | Tectonic Therapeutic, Inc. (TECX) | 24-Sep-24 | Disposition (other) | 1,240,890 | -- | -- | (23%) 5.48M to 4.24M | |
20-Aug-24 7:10 PM View: | Morphic Holding, Inc. (MORF) | 16-Aug-24 | Disposition (change in control) | 4,608,050 | -- | -- | (62%) 7.42M to 2.81M | |
20-Aug-24 7:10 PM View: | Morphic Holding, Inc. (MORF) | 16-Aug-24 | Disposition (change in control) | 2,811,770 | -- | -- | (100%) 2.81M to 0 | |
14-Aug-24 4:43 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 12-Aug-24 | Purchase | 8,016 | $12.72 | $101,968.00 | < 1% 6.31M to 6.32M | |
05-Jul-24 4:02 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 02-Jul-24 | Grant | 1,636,830 | $20.00 | $32,736,600.00 | 26% 6.31M to 7.95M | |
05-Jul-24 4:02 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 02-Jul-24 | Grant | 722,668 | $20.00 | $14,453,400.00 | 9% 7.95M to 8.67M | |
24-Jun-24 4:30 PM View: | Tectonic Therapeutic, Inc. (TECX) | 20-Jun-24 | Grant | 2,692,000 | -- | -- | 100% 0 to 2.69M | |
24-Jun-24 4:30 PM View: | Tectonic Therapeutic, Inc. (TECX) | 20-Jun-24 | Grant | 1,551,120 | -- | -- | 58% 2.69M to 4.24M | |
10-Apr-24 9:40 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 4,130,850 | -- | -- | 275% 1.5M to 5.63M | |
10-Apr-24 9:40 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 826,169 | -- | -- | 15% 5.63M to 6.46M | |
10-Apr-24 9:40 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 123,925 | -- | -- | (2%) 6.46M to 6.34M | |
10-Apr-24 9:40 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 24,785 | -- | -- | (< 1%) 6.34M to 6.31M | |
26-Mar-24 4:32 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 26-Mar-24 | Option Exercise | 1,970,440 | $1.46 | $2,876,850.00 | 5% 38.63M to 40.6M | |
20-Mar-24 5:09 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 18-Mar-24 | Private Purchase | 19,044 | $0.60 | $11,397.80 | < 1% 38.61M to 38.63M | |
28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 18-Mar-24 | Purchase | 800 | $0.61 | $488.00 | < 1% 40.62M to 40.62M | |
18-Mar-24 5:29 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Mar-24 | Purchase | 537,500 | $0.59 | $314,545.00 | 1% 38.07M to 38.61M | |
28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Mar-24 | Purchase | 1,200 | $0.56 | $672.00 | < 1% 40.62M to 40.62M | |
18-Mar-24 5:29 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 14-Mar-24 | Private Purchase | 648,372 | $0.54 | $351,677.00 | 2% 37.43M to 38.07M | |
28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 14-Mar-24 | Purchase | 2,000 | $0.53 | $1,061.00 | < 1% 40.62M to 40.62M | |
28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 13-Mar-24 | Purchase | 3,200 | $0.58 | $1,867.84 | < 1% 40.61M to 40.62M | |
28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 12-Mar-24 | Purchase | 1,200 | $0.61 | $734.64 | < 1% 40.61M to 40.61M | |
28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 11-Mar-24 | Purchase | 1,200 | $0.65 | $784.92 | < 1% 40.61M to 40.61M | |
28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 08-Mar-24 | Purchase | 4,800 | $0.66 | $3,186.72 | < 1% 40.61M to 40.61M | |
28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 07-Feb-24 | Purchase | 2,400 | $0.66 | $1,575.12 | < 1% 40.6M to 40.61M | |
28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 06-Feb-24 | Purchase | 800 | $0.65 | $520.00 | < 1% 40.6M to 40.6M | |
28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 17-Jan-24 | Private Purchase | 800 | $0.69 | $552.00 | < 1% 40.6M to 40.6M | |
04-Jan-24 5:06 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 178,000 | -- | -- | < 1% 37.25M to 37.43M | |
15-Nov-23 5:20 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-23 | Grant | 24,785 | $403.47 | $10,000,000.00 | < 1% 37.25M to 37.27M | |
15-Nov-23 5:20 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-23 | Grant | 123,925 | $403.47 | $50,000,000.00 | < 1% 37.27M to 37.4M | |
30-Jun-23 7:03 PM View: | Morphic Holding, Inc. (MORF) | 28-Jun-23 | Acquisition (other) | 429 | -- | -- | < 1% 7.42M to 7.42M | |
30-Jun-23 7:03 PM View: | Morphic Holding, Inc. (MORF) | 28-Jun-23 | Acquisition (other) | 429 | -- | -- | < 1% 7.42M to 7.42M | |
04-May-23 10:00 PM View: | Morphic Holding, Inc. (MORF) | 03-May-23 | Market Purchase | 1,050,000 | $45.00 | $47,250,000.00 | 16% 6.37M to 7.42M | 5% |
13-Feb-23 4:14 PM View: | Morphic Holding, Inc. (MORF) | 13-Feb-23 | Grant | 42,432 | $35.35 | $1,499,970.00 | < 1% 5.52M to 5.56M | |
13-Feb-23 4:14 PM View: | Morphic Holding, Inc. (MORF) | 13-Feb-23 | Grant | 806,223 | $35.35 | $28,500,000.00 | 14% 5.56M to 6.37M |